Form 4 for RXST RxSight, Inc.
Accepted 2025-06-04 00:00:00 ET · period of report 2025-06-03 · accession 0000950170-25-081963 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-04 | 2025-06-03 | RXST | LINK WILLIAM J PHD | Dir | A - Grant | — | +10.8K | 37.9K | +40% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-03 | A | A | 10,752 | — | 37,855 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. (F2) Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 3, 2025. |